Literature DB >> 11158656

Intensity-modulated parametric mapping for simultaneous display of rapid dynamic and high-spatial-resolution breast MR imaging data.

A T Agoston1, B L Daniel, R J Herfkens, D M Ikeda, R L Birdwell, S G Heiss, A M Sawyer-Glover.   

Abstract

Contrast material-enhanced magnetic resonance (MR) imaging of the breast has variable specificity for differentiation of breast cancer from other enhancing conditions. Two principal strategies to improve its specificity are rapid dynamic MR imaging and high-spatial-resolution MR imaging. A method was developed of combining contemporaneously acquired dynamic and high-spatial-resolution MR imaging data into a single integrated display. Whole-breast rapid dynamic data were condensed into a color map by using pharmacokinetic analysis. The pharmacokinetic results were combined with the high-spatial-resolution images with a new technique that preserves underlying morphologic details. This new method was evaluated by five radiologists for eight breast lesions, and the results were compared with those of the standard method of overlaying parametric map data. The radiologists' ratings showed a statistically significant preference for the intensity-modulated parametric map display method over the overlaid parametric display method for 10 of the 12 evaluation criteria. The new method enabled simultaneous visualization of pharmacokinetic and morphologic information, facilitated assessment of lesion extent, and improved the suppression of noise in the pharmacokinetic data. The ability to simultaneously assess both dynamic and high-spatial-resolution features may ultimately improve the specificity of breast MR imaging.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158656     DOI: 10.1148/radiographics.21.1.g01ja22217

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  9 in total

1.  Combination of low and high resolution sequences in two orientations for dynamic contrast-enhanced MRI of the breast: more than a compromise.

Authors:  Toni W Vomweg; Andrea Teifke; R Peter Kunz; Christian Hintze; Alexander Hlawatsch; Annett Kern; Karl F Kreitner; Manfred Thelen
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

2.  Global Compartmental Pharmacokinetic Models for Spatiotemporal SPECT and PET Imaging.

Authors:  Eric Clarkson; Matthew A Kupinski
Journal:  SIAM J Imaging Sci       Date:  2009-01       Impact factor: 2.867

3.  Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography.

Authors:  E A M Hauth; H Jaeger; S Maderwald; C Stockamp; A Mühler; R Kimmig; M Forsting
Journal:  Eur Radiol       Date:  2006-07-29       Impact factor: 5.315

4.  Dynamic breast MR imaging: is parametric mapping superior to image subtraction in lesion detection?

Authors:  Kathinka D Kurz; Hans-Jörg Wittsack; Reinhart Willers; Dirk Blondin; Ulrich Mödder; Andreas Saleh
Journal:  Eur Radiol       Date:  2007-06-16       Impact factor: 5.315

Review 5.  Fusion viewer: a new tool for fusion and visualization of multimodal medical data sets.

Authors:  Karl G Baum; María Helguera; Andrzej Krol
Journal:  J Digit Imaging       Date:  2007-10-25       Impact factor: 4.056

6.  Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.

Authors:  Kathleen C Horst; Katherine E Fero; Steven L Hancock; Ranjana H Advani; Debra M Ikeda; Bruce Daniel; Saul A Rosenberg; Sarah S Donaldson; Richard T Hoppe
Journal:  Am J Clin Oncol       Date:  2016-04       Impact factor: 2.339

7.  Evaluation of novel genetic algorithm generated schemes for positron emission tomography (PET)/magnetic resonance imaging (MRI) image fusion.

Authors:  K G Baum; E Schmidt; K Rafferty; A Krol; María Helguera
Journal:  J Digit Imaging       Date:  2011-12       Impact factor: 4.056

8.  Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage.

Authors:  Allison W Kurian; Anne-Renee Hartman; Meredith A Mills; James M Ford; Bruce L Daniel; Sylvia K Plevritis
Journal:  Health Expect       Date:  2005-09       Impact factor: 3.377

9.  MRI and (1)H MRS of the breast: presence of a choline peak as malignancy marker is related to K21 value of the tumor in patients with invasive ductal carcinoma.

Authors:  Patricia R Geraghty; Maurice A A J van den Bosch; Daniel M Spielman; Sandeep Hunjan; Robyn L Birdwell; Katherine J Fong; Lara A Stables; Marowan Zakhour; Robert J Herfkens; Debra M Ikeda
Journal:  Breast J       Date:  2008-10-13       Impact factor: 2.431

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.